Centessa Pharmaceuticals plc

Contributing Author

Recent Articles by Centessa Pharmaceuticals plc

Jun-16	Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year CNTA GlobeNewswire
May-19	Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences CNTA GlobeNewswire
May-14	Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025 CNTA GlobeNewswire